KEGG   PATHWAY: pleu05213
Entry
pleu05213                   Pathway                                
Name
Endometrial cancer - Peromyscus leucopus (white-footed mouse)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
pleu05213  Endometrial cancer
pleu05213

Disease
H00026  Endometrial cancer
Organism
Peromyscus leucopus (white-footed mouse) [GN:pleu]
Gene
114680676  Bad; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
114680796  Pdpk1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
114681270  Ctnnb1; catenin beta-1 isoform X1 [KO:K02105]
114681524  Akt2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
114681591  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
114681621  Sos1; son of sevenless homolog 1 [KO:K03099]
114682692  Egf; pro-epidermal growth factor [KO:K04357]
114682732  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
114682816  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
114683055  Tcf7; transcription factor 7 isoform X2 [KO:K02620]
114683440  [KO:K05689]
114683843  Ilk; integrin-linked protein kinase isoform X1 [KO:K06272] [EC:2.7.11.1]
114684032  Pik3cd; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
114684081  Apc2; LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085]
114684224  Sos2; son of sevenless homolog 2 isoform X1 [KO:K03099]
114684640  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
114685127  [KO:K02833]
114685379  Mlh1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
114688121  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
114688301  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
114688488  [KO:K02833]
114688966  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
114689482  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
114689636  Raf1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
114690442  Axin2; axin-2 [KO:K04385]
114690660  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
114691497  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 isoform X2 [KO:K04368] [EC:2.7.12.2]
114693171  Tp53; cellular tumor antigen p53 [KO:K04451]
114693493  [KO:K02833]
114693559  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
114693595  Hras; GTPase HRas isoform X1 [KO:K02833]
114694443  Ctnna2; LOW QUALITY PROTEIN: catenin alpha-2 [KO:K05691]
114694498  Ccnd1; G1/S-specific cyclin-D1 isoform X2 [KO:K04503]
114694653  Polk; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
114695335  Pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
114696553  [KO:K02833]
114697060  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
114698582  Nras; GTPase NRas [KO:K07828]
114699687  Ddb2; DNA damage-binding protein 2 [KO:K10140]
114700859  Casp9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
114700921  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
114701114  Ctnna3; catenin alpha-3 isoform X2 [KO:K05691]
114701479  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
114701991  Myc; myc proto-oncogene protein [KO:K04377]
114703046  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
114703850  Pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
114703900  Araf; serine/threonine-protein kinase A-Raf isoform X2 [KO:K08845] [EC:2.7.11.1]
114703932  Elk1; ETS domain-containing protein Elk-1 isoform X2 [KO:K04375]
114704332  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
114705104  Ctnna1; catenin alpha-1 isoform X1 [KO:K05691]
114705120  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
114705532  Egfr; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
114706143  Bak1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
114706157  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
114706830  Braf; LOW QUALITY PROTEIN: serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
114706924  Pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
114706940  Erbb2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
114707024  Grb2; growth factor receptor-bound protein 2 [KO:K04364]
114707517  Foxo3; LOW QUALITY PROTEIN: forkhead box protein O3 [KO:K09408]
114708477  Kras; GTPase KRas isoform X2 [KO:K07827]
114709466  Axin1; axin-1 isoform X1 [KO:K02157]
114710523  [KO:K04371] [EC:2.7.11.24]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
pleu04010  MAPK signaling pathway
pleu04012  ErbB signaling pathway
pleu04060  Cytokine-cytokine receptor interaction
pleu04110  Cell cycle
pleu04115  p53 signaling pathway
pleu04151  PI3K-Akt signaling pathway
pleu04310  Wnt signaling pathway
pleu04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system